Follow
Ulrike Breitinger
Title
Cited by
Cited by
Year
X-ray structure of 12-oxophytodienoate reductase 1 provides structural insight into substrate binding and specificity within the family of OYE
C Breithaupt, J Strassner, U Breitinger, R Huber, P Macheroux, A Schaller, ...
Structure 9 (5), 419-429, 2001
1412001
Viroporins and inflammasomes: a key to understand virus-induced inflammation
NS Farag, U Breitinger, HG Breitinger, MA El Azizi
The international journal of biochemistry & cell biology 122, 105738, 2020
1092020
The three-dimensional structure of cystathionine β-lyase from Arabidopsis and its substrate specificity
U Breitinger, T Clausen, S Ehlert, R Huber, B Laber, F Schmidt, E Pohl, ...
Plant physiology 126 (2), 631-642, 2001
632001
The p7 viroporin of the hepatitis C virus contributes to liver inflammation by stimulating production of Interleukin-1β
NS Farag, U Breitinger, M El-Azizi, HG Breitinger
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1863 (3), 712-720, 2017
392017
Conserved high affinity ligand binding and membrane association in the native and refolded extracellular domain of the human glycine receptor α1-subunit
U Breitinger, HG Breitinger, F Bauer, K Fahmy, D Glockenhammer, ...
Journal of Biological Chemistry 279 (3), 1627-1636, 2004
372004
Viroporins: Structure, function, and their role in the life cycle of SARS-CoV-2
U Breitinger, NS Farag, H Sticht, HG Breitinger
The international journal of biochemistry & cell biology 145, 106185, 2022
362022
Synergistic Inhibition of Glycinergic Transmission In Vitro and In Vivo by Flavonoids and Strychnine
K Raafat, U Breitinger, L Mahran, N Ayoub, HG Breitinger
Toxicological Sciences 118 (1), 171-182, 2010
362010
Inhibition of SARS CoV envelope protein by flavonoids and classical viroporin inhibitors
U Breitinger, NKM Ali, H Sticht, HG Breitinger
Frontiers in microbiology 12, 692423, 2021
332021
Novel regulatory site within the TM3–4 loop of human recombinant α3 glycine receptors determines channel gating and domain structure
HG Breitinger, C Villmann, N Melzer, J Rennert, U Breitinger, ...
Journal of biological chemistry 284 (42), 28624-28633, 2009
302009
Modulators of the inhibitory glycine receptor
U Breitinger, HG Breitinger
ACS Chemical Neuroscience 11 (12), 1706-1725, 2020
272020
PKA and PKC modulators affect ion channel function and internalization of recombinant alpha1 and alpha1-beta glycine receptors
U Breitinger, LM Bahnassawy, D Janzen, V Roemer, CM Becker, ...
Frontiers in molecular neuroscience 11, 154, 2018
272018
Patch-clamp study of hepatitis C p7 channels reveals genotype-specific sensitivity to inhibitors
U Breitinger, NS Farag, NKM Ali, HGA Breitinger
Biophysical journal 110 (11), 2419-2429, 2016
242016
Molecular dynamics simulation links conformation of a pore-flanking region to hyperekplexia-related dysfunction of the inhibitory glycine receptor
HG Breitinger, H Lanig, C Vohwinkel, C Grewer, U Breitinger, T Clark, ...
Chemistry & biology 11 (10), 1339-1350, 2004
242004
Glucose is a positive modulator for the activation of human recombinant glycine receptors
U Breitinger, KM Raafat, HG Breitinger
Journal of neurochemistry 134 (6), 1055-1066, 2015
222015
Augmentation of glycine receptor alpha3 currents suggests a mechanism for glucose-mediated analgesia
U Breitinger, HG Breitinger
Neuroscience Letters 612, 110-115, 2016
172016
Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting–Part I: In vitro Release and Intracellular Uptake Perspective
AA Sebak, IEO Gomaa, AN ElMeshad, MH Farag, U Breitinger, ...
International journal of nanomedicine, 8845-8862, 2020
162020
Kavalactones from Kava (Piper methysticum) root extract as modulators of recombinant human glycine receptors
NH Hegazy, HG Breitinger, U Breitinger
Biological chemistry 400 (9), 1205-1215, 2019
152019
Modulation of recombinant human α1 glycine receptors by mono-and disaccharides: a kinetic study
U Breitinger, H Sticht, HG Breitinger
ACS Chemical Neuroscience 7 (8), 1077-1087, 2016
152016
Delivery of trans-membrane proteins by liposomes; the effect of liposome size and formulation technique on the efficiency of protein delivery
M Sakla, U Breitinger, HG Breitinger, S Mansour, SN Tammam
International Journal of Pharmaceutics 606, 120879, 2021
132021
Distinct proteins in protein corona of nanoparticles represent a promising venue for endogenous targeting–part ii: In vitro and in vivo kinetics study
AA Sebak, IEO Gomaa, AN ElMeshad, MH Farag, U Breitinger, ...
International Journal of Nanomedicine, 9539-9556, 2020
132020
The system can't perform the operation now. Try again later.
Articles 1–20